125 related articles for article (PubMed ID: 29987158)
1. What do I need to know about fluoroquinolones for children?
Meesters K; Raes AM; Vande Walle JG
Arch Dis Child Educ Pract Ed; 2019 Oct; 104(5):254-258. PubMed ID: 29987158
[No Abstract] [Full Text] [Related]
2. Impact of syndrome-specific antimicrobial stewardship interventions on use of and resistance to fluoroquinolones: An interrupted time series analysis.
Hecker MT; Son AH; Murphy NN; Sethi AK; Wilson BM; Watkins RR; Donskey CJ
Am J Infect Control; 2019 Aug; 47(8):869-875. PubMed ID: 30850252
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial resistance--fluoroquinolones and the tiger's tail.
Tillotson GS; Carroll J; Klugman KP
J Chemother; 2006 Jun; 18(3):328-30. PubMed ID: 17129847
[No Abstract] [Full Text] [Related]
4. [High-Antimicrobial Resistance to Fluoroquinolones by Campylobacter in Pediatric Patients in a Peruvian Hospital].
Moya-Salazar J; Terán-Vásquez A; Salazar-Hernández R
Rev Peru Med Exp Salud Publica; 2018; 35(1):156-158. PubMed ID: 29924265
[No Abstract] [Full Text] [Related]
5. [Dynamics of staphylococcus aureus antibiotic resistance to fluoroquinolones in vitro in patients with overweight].
Dukhovich TV; Chopei IV; Chubirko KI
Wiad Lek; 2018; 71(2 pt 1):301-305. PubMed ID: 29729160
[TBL] [Abstract][Full Text] [Related]
6. Emerging antibiotic resistance in ocular infections and the role of fluoroquinolones.
McDonald M; Blondeau JM
J Cataract Refract Surg; 2010 Sep; 36(9):1588-98. PubMed ID: 20692574
[TBL] [Abstract][Full Text] [Related]
7. Streptococcus pneumoniae clinical isolate highly resistant to fluoroquinolones in a child.
Huang TD; Avrain L; de Bilderling G; Glupczynski Y
Pediatr Infect Dis J; 2006 Dec; 25(12):1195-6. PubMed ID: 17133175
[No Abstract] [Full Text] [Related]
8. Fluoroquinolone antibiotics in infants and children.
Schaad UB
Infect Dis Clin North Am; 2005 Sep; 19(3):617-28. PubMed ID: 16102652
[TBL] [Abstract][Full Text] [Related]
9. Will fluoroquinolones ever be recommended for common infections in children?
Schaad UB
Pediatr Infect Dis J; 2007 Oct; 26(10):865-7. PubMed ID: 17901790
[No Abstract] [Full Text] [Related]
10. Antimicrobial resistance in Campylobacter.
Iovine NM; Blaser MJ
Emerg Infect Dis; 2004 Jul; 10(7):1346. PubMed ID: 15338553
[No Abstract] [Full Text] [Related]
11.
Fernández-Huerta M; Barberá MJ; Serra-Pladevall J; Esperalba J; Martínez-Gómez X; Centeno C; Pich OQ; Pumarola T; Espasa M
Int J STD AIDS; 2020 Mar; 31(3):190-197. PubMed ID: 32000587
[No Abstract] [Full Text] [Related]
12. Fluoroquinolone antimicrobial drugs.
Chan T; Bunce PE
CMAJ; 2017 May; 189(17):E638. PubMed ID: 28461376
[No Abstract] [Full Text] [Related]
13. Clinical need for ototopical fluoroquinolones outweighs miniscule risk of antibiotic resistance.
Couzos S; Councillor H
J Paediatr Child Health; 2006 Apr; 42(4):223-4. PubMed ID: 16630330
[No Abstract] [Full Text] [Related]
14. Streptococcus pneumoniae: the evolution of antimicrobial resistance to beta-lactams, fluoroquinolones and macrolides.
Cornick JE; Bentley SD
Microbes Infect; 2012 Jul; 14(7-8):573-83. PubMed ID: 22342898
[TBL] [Abstract][Full Text] [Related]
15. The newer fluoroquinolones.
Bolon MK
Infect Dis Clin North Am; 2009 Dec; 23(4):1027-51, x. PubMed ID: 19909896
[TBL] [Abstract][Full Text] [Related]
16. [Activities of antimicrobial agents against 8,474 clinical isolates obtained from 37 medical institutions during 2000 in Japan].
Yamaguchi K; Ohno A; Kashitani F; Iwata M; Kanda M; Tsujio Y; Sugiyama T; Toyoshima S; Kato J; Watanabe N; Kaku M; Kanemitsu K; Kunishima H; Kawaguchi H; Okada J; Shimoyama N; Igari J; Oguri T; Kaimori M; Watanabe K; Kobayashi Y; Uchida H; Katayama Y; Sugimoto K; Tashiro H; Kanno H; Yasujima M; Itoh K; Suwabe A; Obata R; Okada M; Kobayashi S; Tsuzimura M; Itoh A; Sumitomo M; Taminato T; Negayama K; Baba H; Makino H; Murase M; Miyamoto H; Minakuchi K; Ishigo S; Takii M; Horii T; Ono J; Takata T; Yamanaka K; Hamazaki N; Tsutsui T; Okabe H; Tatewaki K; Moro K; Hiramatsu K; Saikawa T; Ichiyama S; Nagasawa Z; Aoki Y; Matsushima T; Niki Y; Hirakata Y; Kohno S; Kuwabara M; Nakagawa K; Kageoka T; Hongo T; Yamane N
Jpn J Antibiot; 2003 Oct; 56(5):341-64. PubMed ID: 14692376
[TBL] [Abstract][Full Text] [Related]
17. [Prediction on the efficacy of fluoroquinolones for anaerobic infections using Monte Carlo simulation].
Mikamo H; Tanaka K; Watanabe K
Jpn J Antibiot; 2007 Dec; 60(6):335-43. PubMed ID: 18447205
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial resistance and genetic characterization of Shigella spp. in Shanxi Province, China, during 2006-2016.
Wang Y; Ma Q; Hao R; Zhang Q; Yao S; Han J; Ren B; Fan T; Chen L; Xu X; Qiu S; Yang H
BMC Microbiol; 2019 May; 19(1):116. PubMed ID: 31142259
[TBL] [Abstract][Full Text] [Related]
19. [Susceptibility of 570 Pseudomonas aeruginosa strains to 11 antimicrobial agents and the mechanism of its resistance to fluoroquinolones].
Lei YC; Wang HB; Sun ZY; Shen ZY
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):403-7. PubMed ID: 12820918
[TBL] [Abstract][Full Text] [Related]
20. Emergence of resistance to fluoroquinolones among gram positive and gram negative clinical isolates.
Nesar S; Shoaib MH; Rahim N; Rehman R
Pak J Pharm Sci; 2012 Oct; 25(4):877-81. PubMed ID: 23010009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
